Beam Therapeutics to Participate in 2025 Jefferies London Healthcare Conference

Core Insights - Beam Therapeutics Inc. is participating in the 2025 Jefferies London Healthcare Conference on November 19, 2025, at 3:30 p.m. GMT [1] - The live webcast of the event will be available on the company's investor website and archived for 60 days [2] Company Overview - Beam Therapeutics is a biotechnology company focused on precision genetic medicines through base editing [3] - The company has developed an integrated platform that includes gene editing, delivery, and internal manufacturing capabilities [3] - Beam's proprietary base editing technology allows for precise and efficient single base changes in targeted genomic sequences without causing double-stranded breaks in DNA [3] - The company aims to advance a diversified portfolio of base editing programs to provide life-long cures for patients with serious diseases [3]